Intranasal Fentanyl in Preterm Infants Undergoing Peripherally Inserted Central Catheter Placement

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

February 9, 2025

Study Completion Date

February 9, 2025

Conditions
Procedural Pain
Interventions
DRUG

Fentanyl

The fentanyl solution for administration will be prepared by diluting 2 mL of fentanyl 50 µg/mL with 8 mL of normal saline (bacteriostatic 0.9% sodium chloride) for a fentanyl solution of 10 µg/mL.

DRUG

Normal saline

The normal saline solution for administration will be bacteriostatic 0.9% sodium chloride.

Trial Locations (1)

M5G 1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Mount Sinai Hospital, Canada

OTHER

NCT06590870 - Intranasal Fentanyl in Preterm Infants Undergoing Peripherally Inserted Central Catheter Placement | Biotech Hunter | Biotech Hunter